Zobrazeno 81 - 90
of 38 677
pro vyhledávání: ''
Autor:
Philipp B. Staber, Peter Bettelheim, Christian Sillaber, Gabriele Stefanzl, Dubravka Smiljkovic, Daniela Berger, Georg Greiner, Peter Valent, Karin Bauer, Wolfgang R. Sperr, Ana-Iris Schiefer, Susanne Gamperl, Ilse Schwarzinger, Renate Thalhammer, Gregor Hoermann, Paul Knöbl, Christoph Kornauth
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 12, Pp 1183-1191 (2021)
Neoplasia (New York, N.Y.)
Neoplasia (New York, N.Y.)
During progression of myeloid neoplasms, the basophil compartment may expand substantially and in some of these patients, a basophilic leukemia is diagnosed. In patients with Ph-chromosome+ chronic myeloid leukemia, acceleration of disease is typical
Autor:
Driele Peixoto, Renata Colombo Bonadio, Juliana Pereira, Odeli Nicole Encinas Sejas, Camilla Hoff, Vanderson Rocha, Gabriel Y. Watarai, Veruska Menegatti Anastacio, Camila Motta Venchiarutti Moniz, Lorena Teixeira Frasson, Edson Abdala, Raquel Keiko de Luca Ito, Guilherme Nader Marta, Maria Del Pilar Estevez-Diz, Maria Cecilia Mathias Machado, Paulo M. Hoff, Ulysses Ribeiro
Publikováno v:
JCO Global Oncology
PURPOSE Patients with cancer are at increased risk for unfavorable outcomes from COVID-19. Knowledge about the outcome determinants of severe acute respiratory syndrome coronavirus 2 infection in this population is essential for risk stratification a
Autor:
Min Deng, Jia-Bao Lin, Rong-Ce Zhao, Shao-Hua Li, Wen-Ping Lin, Jing-Wen Zou, Wei Wei, Rong-Ping Guo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Cancer
BMC Cancer
Background The accuracy of existing biomarkers for predicting the prognosis of hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that can accurately predict the prognosis of HCC. Methods In this study, original
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8483-8496 (2021)
Cancer Medicine
Cancer Medicine
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains controversial. In the present study, we aimed to investigate whether elderly patients with stage II–III EC could benefit from trimodal therapy. Methods The se
Autor:
Eva Karamitopoulou, Aurélie Pahud de Mortanges, Aurel Perren, Beat Gloor, Andreas Andreou, Marianne Tinguely
Publikováno v:
Cancer Immunology Research. 9:1439-1450
Immunotherapy, including PD-1/PD-L1 agonists, has shown limited efficacy in pancreatic ductal adenocarcinoma (PDAC). We examined the PD-1/PD-L1 expression and immunoarchitectural features by automated morphometric analysis using multiplex immunofluor
Autor:
Tawfiqul Bhuiya, Juan P. Idrovo, Jin Cao, Pooja Navale, Louis J. Auguste, Sudarshana Roychoudhury, Silvat Sheikh-Fayyaz, Hua Guo
Publikováno v:
Clinical Breast Cancer. 21:e638-e646
This study explored human papillomavirus (HPV) amplification in breast benign and malignant lesions by chromogenic in situ hybridization (CISH) and the concordance of p16 expression by immunohistochemistry.The presence of HPV6/11 and HPV16/18 in 33 c
Autor:
Li Pang, Zhiqiang Guo
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8558-8569 (2021)
Cancer Medicine
Cancer Medicine
Background There is currently no recognized first‐line treatment strategy for ovarian neuroendocrine tumors (NETs). Furthermore, because of the low incidence of ovarian NETs, no studies have reported prognostic statistics derived from large samples
Publikováno v:
Cancer Medicine, Vol 10, Iss 24, Pp 8909-8923 (2021)
Cancer Medicine
Cancer Medicine
Background There is limited and controversial evidence on the prognosis of partial nephrectomy (PN) versus radical nephrectomy (RN) in patients with T3aN0/xM0 renal cell carcinoma (RCC) upstaged from clinical T1 RCC. In this study, we aimed to assess
Autor:
Atsushi Naganuma, Takaaki Tanaka, Atsushi Hiraoka, Satoshi Yasuda, Kazuya Kariyama, Noritomo Shimada, Shinichiro Nakamura, Satoru Kakizaki, Michitaka Imai, Koichi Takaguchi, Takuya Nagano, Toshifumi Tada, Akemi Tsutsui, Takashi Kumada, Takeshi Hatanaka, Kazuhiro Nouso, Toru Ishikawa, Kunihiko Tsuji, Hidenori Toyoda, Hiroshi Shibata, Ei Itobayashi
Publikováno v:
Oncology
Background/Aim: With the development of systemic treatment methods for unresectable hepatocellular carcinoma (uHCC), the concept of unsuitable for transcatheter arterial chemoembolization (TACE) has become important. This study aimed to establish a s
Autor:
Zahra Madjd, Mahdieh Razmi, Sima Saki, Elham Kalantari, Leili Saeednejad Zanjani, Monireh Mohsenzadegan, Fahimeh Fattahi, Maryam Abolhasani
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 148:609-631
Melanoma-associated antigen A2 (MAGE-A2) is a member of the cancer-testis antigen family differentially overexpressed in a variety of malignancies and is associated with tumor development. However, clinical significance and prognostic value of MAGE-A